Size reduction of a prolactin secreting adenoma during long-term treatment with the dopamine agonist lisuride
- PMID: 7379313
- DOI: 10.1111/j.1365-2265.1980.tb03131.x
Size reduction of a prolactin secreting adenoma during long-term treatment with the dopamine agonist lisuride
Abstract
A 38-year-old amenorrhoeic woman suffering from a prolactin (PRL) secreting adenoma, which had suprasellar extension as shown by caroe agonist (lisuride). PRL levels were lowered and after 1 year of treatment CAT showed a marked reduction of the tumour size. After 2 years of treatment menstruation returned and CAT demonstrated a further reduction of the adenomatous tissue. This study supports the suggestion that dopamine agonists possess an anti-proliferative effect on tumoural lactotrophic cells of humans.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
